Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.

Author: ChenHonghui, FangMaosheng, HuangJizhong, LiLe-Hua, LiYi, LiuLianzhong, WangBo, WangGang, WuRenrong, YeMeng, ZhangLulu, ZhangQinge, ZhaoJing-Ping, ZhengHongbo, ZhouJianchu, ZhuSuoyu

Paper Details 
Original Abstract of the Article :
This randomized, parallel-group, open study investigated the efficacy and safety of risperidone oral solution (RIS-OS) in combination with clonazepam and intramuscular haloperidol for the treatment of acute agitation in patients with schizophrenia, and the study explored the possibility of decreasin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/YIC.0b013e32834fc431

データ提供:米国国立医学図書館(NLM)

A Comparative Study of Risperidone Oral Solution and Haloperidol in Treating Schizophrenia

In the realm of psychiatric treatment, this study provides a comparative analysis of risperidone oral solution (RIS-OS) and intramuscular haloperidol, both used to manage acute agitation in patients with schizophrenia.

The Quest for Effective Treatment

The researchers conducted a randomized, open study involving 205 patients with schizophrenia experiencing acute agitation. They aimed to determine the efficacy and safety of RIS-OS in combination with clonazepam compared to intramuscular haloperidol.

Key Findings and Implications

The study discovered that both RIS-OS and haloperidol were effective in reducing agitation, with similar efficacy after 5 days of treatment. The oral treatment demonstrated greater efficacy in reducing extrapyramidal symptoms, a significant advantage for patients.

Health Implications and Treatment Choices

These findings suggest that RIS-OS, when combined with clonazepam, offers a viable and well-tolerated alternative to intramuscular haloperidol for managing acute agitation in schizophrenia.

Dr.Camel's Conclusion

Imagine a vast desert with two paths leading to a distant oasis. This study helps us choose the path that is not only effective but also provides a smoother journey, reducing the risk of side effects along the way.
Date :
  1. Date Completed 2012-06-04
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

22233697

DOI: Digital Object Identifier

10.1097/YIC.0b013e32834fc431

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.